Japanese Medtech Startup, CoreTissue BioEngineering, Initiates Randomized Controlled Cohort in the Clinical Trial for Anterior Cruciate Ligament (ACL) Reconstruction Treatment Business Wire
News
Q&A
Shopping
Auction
Rakuten
amazon